Treatment With Ranolazine in Microvascular Coronary Dysfunction (MCD): Impact on Angina Myocardial Ischemia
Phase of Trial: Phase III
Latest Information Update: 22 Dec 2016
At a glance
- Drugs Ranolazine (Primary)
- Indications Angina pectoris
- Focus Therapeutic Use
- Acronyms RWISE
- 07 Jun 2017 Biomarkers information updated
- 22 Dec 2016 Results of retrospective tissue tracking analysis assessing systolic/diastolic strain, using cardiac magnetic resonance imaging cine images acquired from RWISE trial (n=128) and healthy reference controls (n=43), published in the Clinical Cardiology.
- 18 Oct 2016 Status changed from recruiting to completed.